Histone deacetylases (HDACs) offer potentially attractive molecular targets for sensitizing cancers to treatment with radiation therapy. By affecting patterns of gene expression, differentiation, apoptosis, and enhanced responses to therapeutic agents may be induced in cancer cells. Here, we review
DNA methylation, histone deacetylase repressory complexes and development
β Scribed by Boris Kantor; Aharon Razin
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 623 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1438-7506
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Epigenetic modification of the cytosine base of DNA by its methylation introduced the possibility that beyond the inherent information contained within the nucleotide sequence there was an additional layer of information added to the underlying genetic code. DNA methylation has been imp
## Abstract During tumorigenesis, cancerβrelated genes can be silenced by aberrant DNA methylation and by changes in chromatin structure. It has been reported that 5βazaβ2β²βdeoxycytidine, a potent inhibitor of DNA methylation, in combination with histone deacetylase inhibitors, can produce a synerg
## Abstract The identification of molecules that are downβregulated in malignant phenotype is important for understanding tumor biology and their role in tumor suppression. We compared the expression profile of four normal nasal mucosal (NNM) epithelia and a series of nasopharyngeal cancinoma (NPC)